AEZS Aeterna Zentaris Inc

QUEBEC CITY, Sept. 25 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (NASDAQ:AEZSNASDAQ:TSX:NASDAQ:AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its President and CEO, Jürgen Engel, PhD, will present a company overview at BioContact Quebec on Thursday, October 2, 2008, at 2:00 pm (eastern time) in the Salle Frontenac of the Fairmont Le Chateau Frontenac hotel in Quebec City, Canada. About AEterna Zentaris Inc. AEterna Zentaris Inc. is global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at http://www.aezsinc.com/. DATASOURCE: AETERNA ZENTARIS INC. CONTACT: Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418) 652-8525 ext. 265, ; Media Relations: Paul Burroughs, Director of Communications, (418) 652-8525 ext. 406,

Copyright